COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Moment of Tru

<< Previous

Bullboard Posts

Next >>

Comment by tigerproon Aug 12, 2024 4:17am

99 Views

Post# 36173905

RE:Re: Moment of Tru

I have sold my shares with big loss. It is my fault to believe a liar CEO.

Gagnon will lead the new company to bankruptcy before he steals the last money from the new company.

No shareholders can kick him off the board for years. It is too amazing. It surprises me a lot and destroys my last confidence. I can only say that some shareholders deserve the result.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property